| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.099 | 0.06 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.095 | 0.07 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.084 | 0.07 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |